Erik Norström
Corporate Officer/Principal at TECAN GROUP AG
Net worth: 825 745 $ as of 29/04/2024
Network origin in Erik Norström first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
40
| Subsidiary | Pharmaceuticals: Major | 40 |
| Public Company | Medical Specialties | 23 | |
Chalmers University of Technology
13
| College/University | Other Consumer Services | 13 |
| Extinct | Food: Specialty/Candy | 8 | |
Andrew Alliance SA
 Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland.
4
| Subsidiary | Industrial Machinery | 4 |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
labforward GmbH
 labforward GmbH Information Technology ServicesTechnology Services labforward GmbH develops a digital laboratory notebook for scientists to organize research, create protocol templates, and collaborate and share with other scientists. The firm offers labfolder, an online platform for the documentation and analysis of experimental scientific data. The company was founded by Simon Bungers, Florian Hauer, and Mathias Schäffner in 2012 and is headquartered in Berlin, Germany.
2
| Holding Company | Information Technology Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Erik Norström via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary Corporate Officer/Principal Human Resources Officer | |
| BAYER AG | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Basel | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| University of Freiburg | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Comptroller/Controller/Auditor | |
| International Institute for Management Development | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Founder Chairman Director/Board Member | |
Hilti AG
 Hilti AG Metal FabricationProducer Manufacturing Hilti AG engages in the development, manufacture, and sale of construction tools and equipment. The company's product portfolio includes anchor systems, construction chemicals, cordless systems, direct fastening, drilling and demolition, firestop, diamond coring and cutting, modular support systems, measuring systems, screw fastening, façade systems, as well as accessories. It also provides system solutions, as well as software and services. The company was founded by Martin Hilti and Eugen Hilti in 1941 and is headquartered in Schaan, Liechtenstein. | Metal Fabrication | Chairman Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Founder Chairman | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| The Rockefeller University | College/University | Doctorate Degree Doctorate Degree | |
| REVVITY, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Nutrition-Wellness Venture AG
 Nutrition-Wellness Venture AG Financial ConglomeratesFinance Part of Nestlé SA, Nutrition-Wellness Venture AG is an investment holding Swiss company. The company is based in Vevey, Switzerland. | Financial Conglomerates | Chairman Director/Board Member | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Freie Universität Berlin | College/University | Doctorate Degree Doctorate Degree | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Leica Microsystems GmbH
 Leica Microsystems GmbH Electronic ComponentsElectronic Technology Leica Microsystems GmbH develops and manufactures high precision optical systems. Its products includes microscopes and imaging solutions, modular microscopers for needs. The company was founded in 1849 and is headquartered in Wetzlar, Germany. | Electronic Components | President Corporate Officer/Principal | |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Analytical Life Science & Diagnostics Association | Director/Board Member Director/Board Member | ||
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| CATALENT, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SCHWEITER TECHNOLOGIES AG | Industrial Machinery | Director/Board Member Director/Board Member | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Corporate Officer/Principal | |
| SULZER LTD | Industrial Machinery | Director/Board Member Comptroller/Controller/Auditor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| STRATEC SE | Medical Specialties | Chairman Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Human Resources Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree |
Statistics
International
| Switzerland | 17 |
| Germany | 13 |
| United States | 13 |
| Denmark | 5 |
| France | 4 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Producer Manufacturing | 4 |
| Finance | 4 |
Operational
| Director/Board Member | 439 |
| Corporate Officer/Principal | 211 |
| Chairman | 159 |
| Independent Dir/Board Member | 79 |
| Chief Executive Officer | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Fredrik Wilhelm Bandhold | 47 |
| Rolf Classon | 47 |
| Bradley Bolzon | 41 |
| Luis Cantarell Rocamora | 35 |
| Erich Maximilian Platzer | 31 |
| Erich Hunziker | 28 |
| Jesper Brandgaard | 28 |
| Heinrich Fischer | 26 |
| Carole Nüchterlein | 26 |
| Jacob Key | 23 |
| Pamela Kirby | 22 |
| Richard T. Laube | 21 |
| Daniel Marshak | 21 |
| Gérard Vaillant | 20 |
| Heino von Prondzynski | 19 |
- Stock Market
- Insiders
- Erik Norström
- Company connections
